| Predicted Trait | |
| Reported Trait | Bladder cancer |
| Mapped Trait(s) | urinary bladder carcinoma (MONDO_0004986) |
| Score Construction | |
| PGS Name | PRS24_BC |
| Development Method | |
| Name | Genome-wide significant SNPs |
| Parameters | NR |
| Variants | |
| Original Genome Build | GRCh37 |
| Number of Variants | 24 |
| Effect Weight Type | log(OR) |
| PGS Source | |
| PGS Catalog Publication (PGP) ID | PGP000796 |
| Citation (link to publication) | Koutros S et al. Eur Urol (2023) |
| Ancestry Distribution | |
| Source of Variant Associations (GWAS) | European: 100% 356,027 individuals (100%) |
| PGS Evaluation | European: 100% 2 Sample Sets |
| Study Identifiers | Sample Numbers | Sample Ancestry | Cohort(s) |
|---|---|---|---|
GWAS Catalog: GCST90296729 |
[
|
European | UKB |
|
PGS Performance Metric ID (PPM) |
PGS Sample Set ID (PSS) |
Performance Source | Trait |
PGS Effect Sizes (per SD change) |
Classification Metrics | Other Metrics | Covariates Included in the Model |
PGS Performance: Other Relevant Information |
|---|---|---|---|---|---|---|---|---|
| PPM030669 | PSS012231| European Ancestry| 41,261 individuals |
PGP000796 | Koutros S et al. Eur Urol (2023) |
Reported Trait: Bladder cancer | HR: 1.51 [1.38, 1.65] | — | — | — | — |
| PPM030670 | PSS012232| European Ancestry| 222,139 individuals |
PGP000796 | Koutros S et al. Eur Urol (2023) |
Reported Trait: Bladder cancer | HR: 1.32 [1.21, 1.44] | — | — | — | — |
|
PGS Sample Set ID (PSS) |
Phenotype Definitions and Methods | Participant Follow-up Time | Sample Numbers | Age of Study Participants | Sample Ancestry | Additional Ancestry Description | Cohort(s) | Additional Sample/Cohort Information |
|---|---|---|---|---|---|---|---|---|
| PSS012232 | — | — | [
|
— | European | — | UKB | — |
| PSS012231 | — | — | [
|
— | European | — | PLCO | — |